ADC Agree Realty Corporation

QT33

Latest market price

67.07

-0.54-0.80%

Overview Short InterestFilings

ADCQT33Agree Realty Corporation·NYSE

Overview Short InterestFilings

67.07-0.80%

News

Down 0.8% — Akari Therapeutics to Highlight Novel RNA-Splicing ADC Payload Strategy at the 3rd Annual ADC Payload Summit (globenewswire.com).

Medium confidence

Loading chart...

Signal & projected range

Earnings big beat — drift (PEAD)Historical pattern — not a prediction

Recent priceDays this stock last showed the setupRange of past outcomes (±1σ)

Horizon

Unlock the projected rangeSee where this setup landed historically — with Premium.

Unlock with Premium

Over the next 20 trading days, similar setups historically landed in a measured range of outcomes. Unlock with Premium to see the median return, the typical range, and how often they were positive. This is the historical range of outcomes — not a prediction of this stock’s price.

Ranges describe how this exact setup resolved in the past — derived from thousands of historical occurrences across QuoTrend’s coverage since 2006, survivorship-corrected to include companies that later delisted. The band is the typical spread (±1σ) of those outcomes, not a forecast; the central value is their average move. Fewer matching cases over longer horizons widen the band and lower its reliability. Backtested results are hypothetical, based on historical data, and do not represent actual trading. Past performance does not guarantee or predict future results. QuoTrend is an educational research tool, not investment advice. Markets involve risk, including loss of principal.

Screen all →

NNN-1.25%$41.00 BRX-0.07%$29.14 FRT-1.12%$110.19 MAC+0.12%$24.34 REG-0.52%$74.59 KRG+0.16%$25.07 PECO+0.34%$38.83 KIM+0.41%$24.52

Snapshot

Index	—	P/E	34.57	EPS (ttm)	1.94	Insider Own	1.85%	Shs Outstand	124.38M	Perf Week	0.55%

Market Cap	8.34B	Forward P/E	33.82	EPS next Y	1.98	Insider Trans	4.24%	Shs Float	121.69M	Perf Month	3.14%

Enterprise Value	12.00B	PEG	9.79	EPS next Q	0.48			Short Float	6.53%	Perf Quarter	-12.79%

Income	241.00M	P/S	10.30	EPS this Y	6.73%			Short Ratio	5.08	Perf Half Y	-12.17%

Sales	810.00M	P/B	1.20	EPS next Y	4.04%	ROA	2.20%	Short Interest	7.94M	Perf YTD	-6.89%

Book/sh	55.82	P/C	102.99	EPS next 5Y	3.53%	ROE	3.72%	52W High	82.08 -18.29%	Perf Year	-8.24%

Cash/sh	0.65	P/FCF	15.92	EPS past 3/5Y	-1.11% 0.34%	ROIC	3.70%	52W Low	64.34 4.24%	Perf 3Y	23.84%

Dividend Est.	3.25 (4.85%)	EV/EBITDA	18.46	Sales past 3/5Y	18.64% 23.59%	Gross Margin	70.46%	Volatility	1.54% 1.76%	Perf 5Y	-4.39%

Dividend TTM	3.44 (5.14%)	EV/Sales	14.82	EPS Y/Y TTM	12.79%	Oper. Margin	49.27%	ATR (14)	1.31	Perf 10Y	39.26%

Dividend Ex-Date	Oct 30, 2026	Quick Ratio	1.21	Sales Y/Y TTM	17.56%	Profit Margin	29.78%	RSI (14)	49.58	Recom	2.27

Dividend Gr. 3/5Y	3.18% 5.08%	Current Ratio	1.21	EPS Q/Q	155.56%	SMA20	1.20%	Beta	0.40	Target Price	76.50

Payout	160.42%	Debt/Eq	0.54	Sales Q/Q	16.94%	SMA50	-2.35%	Rel Volume	1.14	Prev Close	67.61

Employees	90	LT Debt/Eq	0.54	Earnings	Feb 09	SMA200	-10.00%	Avg Volume	1.64M	Price	67.07

IPO Date	Apr 15, 1994	Option/Short	Yes / Yes	EPS/Sales Surpr.	143.17% 1.12%	Net Debt/EBITDA	5.63	Volume	1,876,829	Change	-0.80%

Analyst Ratings

Date	Action	Analyst	Rating	Target
Oct-27-26	Reiterated	Keybanc	Overweight	$82 → $76
Oct-21-26	Reiterated	Stifel Nicolaus	Buy	$82 → $77
Oct-21-26	Reiterated	Robert W. Baird		$77 → $76
Oct-20-26	Reiterated	Barclays	Equal Weight	$85 → $76
Oct-01-26	Reiterated	Truist Financial	Buy	$82 → $75
Sep-17-26	Reiterated	Mizuho	Neutral	$80 → $72
Jul-31-26	Reiterated	Robert W. Baird		$82 → $83
Jul-22-26	Reiterated	Barclays	Equal Weight	$84 → $85
Jun-01-26	Reiterated	Jefferies	Buy	$80 → $84
May-19-26	Reiterated	Barclays	Equal Weight	$86 → $84

Latest News· Times ET

Nov-01-26

Nov-01-2607:07AM

The 10-Year Treasury Yield Fell 33 Basis Points. Here Are 5 Net-Lease REITs to Watch247wallst.com

Oct-31-26

Oct-31-2607:15AM

If I Could Only Buy 3 REITs After The Sell-Offseekingalpha.com

Oct-30-26

Oct-30-2612:47PM

Realty Income and Agree Realty Both Raised Guidance. Which Dividend Looks Stronger?247wallst.com

09:05AM

Akari Therapeutics to Highlight Novel RNA-Splicing ADC Payload Strategy at the 3rd Annual ADC Payload Summitglobenewswire.com

Oct-29-26

Oct-29-2607:30AM

ADC Therapeutics Announces ZYNLONTA® Updates in Japanprnewswire.com

04:47AM

Undercovered Dozen: Micron, i-80 Gold, Hercules Capital, And Moreseekingalpha.com

Oct-28-26

Oct-28-2609:42AM

How Large Does Your Portfolio Need to Be to Generate $10,300 a Month?247wallst.com

Oct-27-26

Oct-27-2611:45AM

5 Best Dividend Stocks with Monthly PayoutYahoo

Oct-26-26

Oct-26-2610:49AM

How Do You Tell a Yield Trap From a Real $6,400-a-Month Dividend Portfolio?247wallst.com

07:45AM

Agree Realty: Not Much Has Changed Except A Better Entry Pointseekingalpha.com

Oct-25-26

Oct-25-2602:45PM

REITs Rebound As Earnings Deliverseekingalpha.com

01:33PM

How to Build $8,300 a Month in Dividend Income Without Owning a Single Bond247wallst.com

12:00PM

Sonesitatug vedotin reduced the risk of death by 42% in 2nd and later-line CLDN18.2-positive advanced gastric/GEJ cancers in CLARITY-Gastric01gurufocus.com

09:00AM

ArriVent Announces Initial Phase 1 Data for CDH17-targeted ADC ARR-217 in Patients with Gastrointestinal Cancers at ESMO Congress 2026globenewswire.com

Oct-24-26

Oct-24-2608:00AM

Bio-Thera Announces Promising Clinical Data for BAT8008 in Combination with BAT1308 in First-Line Non-Small Cell Lung Cancer at ESMO 2026gurufocus.com

Company

Agree Realty Corporation functions as a publicly traded Real Estate Investment Trust (REIT), concentrating its efforts on the acquisition and development of commercial properties. These assets are primarily net-leased to leading companies within the retail sector. As of September 30, 2020, the firm oversaw a substantial portfolio of 1,027 properties, which were distributed across 45 U.S. states and encompassed a total gross leasable area of approximately 21.0 million square feet. Shares of Agree Realty's common stock are available for trade on the New York Stock Exchange, identified by the ticker symbol ADC.

Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements

DataTimeframe

Line Item (USD, M)	TTM —	FY 2025 12/31/2025	FY 2024 12/31/2024	FY 2023 12/31/2023	FY 2022 12/31/2022	FY 2021 12/31/2021	FY 2020 12/31/2020	FY 2019 12/31/2019	FY 2018 12/31/2018
Total Revenue	810	718	617	537	—	—	—	—	—
Cost of Goods Sold Incl. D&A	239	88	75	67	—	—	—	—	—
Gross Profit	571	630	542	471	—	—	—	—	—
Selling, General and Administrative Excl. Other	46	44	37	35	—	—	—	—	—
Research and Development	0	0	0	0	—	—	—	—	—
Other Operating Expense	125	246	203	181	—	—	—	—	—
Operating Income	400	340	302	254	—	—	—	—	—
Interest Expense	152	135	109	81	—	—	—	—	—
Unusual Expense	—	—	—	—	—	—	—	—	—
Non-Operating Income (Expense)	31	1	1	0	—	—	—	—	—
Net Income Before Taxes	279	207	194	173	—	—	—	—	—
Income Taxes	0	2	4	3	—	—	—	—	—
Consolidated Net Income	241	204	189	170	—	—	—	—	—
Net Income From Continuing Operations	279	205	190	171	—	—	—	—	—
Net Income	241	204	189	170	—	—	—	—	—
EPS (Recurring)	1.94	1.77	1.79	1.70	—	—	—	—	—
EPS (Basic, Before Extraordinaries)	1.94	1.77	1.79	1.70	—	—	—	—	—
EPS (Diluted)	1.94	1.77	1.78	1.70	—	—	—	—	—
EBITDA	650	617	543	464	—	—	—	—	—
Other After Tax Adjustments	—	—	—	—	—	—	—	—	—
Stock Option Compensation Expense	—	—	—	—	—	—	—	—	—
Price To Earnings Ratio	34.57	40.69	39.58	37.03	—	—	—	—	—
Price To Sales Ratio	10.27	11.14	11.53	11.14	—	—	—	—	—
Gross Margin	70.49	87.74	87.84	87.71	—	—	—	—	—
Operating Margin	49.38	47.35	48.95	47.30	—	—	—	—	—
Net Margin	29.75	28.41	30.63	31.66	—	—	—	—	—
Shares Outstanding	124	111	101	95	—	—	—	—	—
Market Capitalization	8,317	7,995	7,115	5,980	—	—	—	—	—
Operating Lease Expense	—	—	—	—	—	—	—	—	—

Unlock full historical data

See years of past statements with Premium.

Unlock with Premium

Insider Trading Volume

Insider Trading

Insider	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Erlich Craig	CHIEF GROWTH OFFICER	Sep 21 '26	Buy	67.55	1,000	67,550	60,388	Sep 23
RAKOLTA JOHN JR	Director	Sep 16 '26	Buy	68.78	20,000	1,375,600	654,602	Sep 17
Agree Joey	PRESIDENT & CEO	Sep 16 '26	Buy	68.06	7,360	500,922	682,465	Sep 17
RAKOLTA JOHN JR	Director	Aug 31 '26	Buy	72.42	10,000	724,200	632,197	Sep 02
RAKOLTA JOHN JR	Director	Aug 28 '26	Buy	73.52	136	9,999	622,197	Aug 31
RAKOLTA JOHN JR	Director	Aug 27 '26	Buy	73.23	20,000	1,464,600	622,061	Aug 31
AGREE RICHARD	EXECUTIVE CHAIRMAN OF BOARD	Jun 04 '26	Buy	71.41	5,000	357,050	90,512	Jun 08
RAKOLTA JOHN JR	Director	May 15 '26	Buy	74.57	20,000	1,491,400	595,798	May 19
Agree Joey	PRESIDENT & CEO	May 14 '26	Buy	75.41	13,295	1,002,576	675,105	May 18
Lehmkuhl Greg	Director	May 14 '26	Buy	75.09	750	56,318	34,465	May 18
RAKOLTA JOHN JR	Director	Apr 01 '26	Buy	75.69	146	11,051	146	Apr 03
Coughenour Peter	CHIEF FINANCIAL OFFICER	Jan 09 '26	Buy	69.80	500	34,900	18,544	Jan 13
AGREE RICHARD	EXECUTIVE CHAIRMAN OF BOARD	Jan 09 '26	Buy	70.67	24,000	1,696,080	159,855	Jan 12
RAKOLTA JOHN JR	Director	Dec 24 '25	Buy	72.18	15,000	1,082,700	562,606	Dec 29
RAKOLTA JOHN JR	Director	Oct 07 '25	Buy	70.41	25,154	1,771,093	553,700	Oct 09

open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR

QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.